missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ EEF2 Monoclonal Antibody (5B6)

Description
MA5-15833 targets EEF2 in indirect ELISA, IF, IHC, and WB applications and shows reactivity with Human samples. The MA5-15833 immunogen is purified recombinant fragment of human EEF2 expressed in E. Coli. . MA5-15833 detects EEF2 which has a predicted molecular weight of approximately 95kDa.
Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome.
Specifications
Specifications
| Antigen | EEF2 |
| Applications | ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | 5B6 |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | ascites with 0.03% sodium azide |
| Gene | EEF2 |
| Gene Accession No. | P13639, P58252 |
| Gene Alias | EEF2; EEF-2; Ef2; EF-2; Elongation factor 2; elongation factor-2; eukaryotic translation elongation factor 2; I79_013848; polypeptidyl-tRNA translocase; SCA26; zef2 |
| Show More |